Peptidylglycine α-amidating monooxygenase (PAM) converts inactive terminal-glycine prohormones into their activated α-amidated forms. PAM is thought to play a role in the development of antiandrogen drug resistance in prostate cancer (CaP) through PAMactivated autocrine growth. On the basis of the previous finding that many lung cancer cell lines excrete PAM into their culture media, this study investigates PAM levels in media collected from human CaP cell line cultures. Androgen-independent DU145 and PC-3 prostate cancer cell lines exhibited readily detectable levels of PAM activity in extracts and media, whereas the androgen-dependent LNCaP cell line showed little or no activity. Because of the much larger volume of media versus cell extracts, more than 90% of the total PAM activity was located in the media for both the PC-3 and DU145 cell lines, providing a readily accessible source of CaP PAM. A simple, scalable method to obtain PAM from the culture media of androgen-independent human prostate cancer cell lines is described in this article. This approach provides a much easier means of collecting CaPderived PAM than previously described cell fractionation procedures and should facilitate the investigations of the role and targeting of PAM in hormone-independent CaP. (Journal of Biomolecular Screening 2008:804-809) 
INTRODUCTION C ONVERSION OF INACTIVE Terminal-Glycine "Prohormones"
into activated α-amidated forms by peptidylglycine αamidating monooxygenase (PAM) is a common posttranslational modification of bioactive peptides such as hormones, neurotransmitters, and growth factors, 1,2 which can increase activity 100-to 10,000-fold. PAM activation involves 2 distinct steps performed by the constituent enzymes peptidylglycine αhydroxylating monooxygenase (PHM) and peptidylamidoglycolate lyase (PAL). PHM replaces the pro-(S) hydrogen of the carboxy-terminal glycine with a hydroxyl group to form an αhydroxyglycine intermediate and is dependent on copper, ascorbic acid, and molecular oxygen. PAL produces the amidated peptide plus glyoxylate 3, 4 and is dependent on zinc. 1, 5 The overall PAM reaction then effectively removes all but the amide group of the protein's terminal-glycine. PAM enzymes are expressed by atrial myocytes, endothelial cells, smooth muscle cells, and bronchial tissues, as well as by neuroendocrine (NE)-differentiated cells in a variety of tissues. 1, 6 Although the tissues express PAM from a single gene, specific processing of the mRNA can yield differences in the enzyme form and routing in different tissues. 2 Membrane-bound forms of PAM contain a carboxy-terminal transmembrane domain, whereas deletion of the transmembrane domain produces a soluble form of PAM. It further has been shown that soluble PAM is stored in the cytosol in some tissues, but it is secreted in other types of cells. 2 NE cell differentiation and resultant PAM production have been implicated in creating autocrine growth loops in small cell lung cancer (SCLC), an aggressive form of lung cancer characterized by NE-differentiated features. 7 SCLC cells produce gastrin-releasing peptide (GRP) prohormone as well as PAM. PAM converts the prohormone to active GRP, which then serves as a growth factor for the cells, forming an autocrine growth loop that is thought to enhance tumor growth and progression. PAM inhibitors have been shown to inhibit the autocrine growth of these SCLC cells. 8 There is some evidence that PAM production by NEdifferentiated prostate cancer (CaP) tumor cells sets up similar autocrine growth loops that play a role in the progression to hormone-refractory CaP. 9 The first line of CaP treatment is antihormone drug therapy, which slows or stops the growth of androgen-dependent prostate cancer cells generally found in the early stages of CaP. Over time, however, CaP cells can become resistant to antihormone therapy. Androgen withdrawal, such as occurs during antiandrogen therapy, leads to the induction of NE cell differentiation 10 and increases the proportion of NE cells in CaP tumors. 11, 12 This NE differentiation greatly increases the expression of PAM, as observed in androgen-independent human CaP cell lines and tumor specimens. 9, 13 Androgen-independent CaP cell lines are also capable of forming autocrine growth loops through the production and PAM activation of proadrenomedullin to form growth-stimulating adrenomedullin. 9 Thus antiandrogen therapy by this mechanism may cause NE differentiation and subsequent PAM production that result in the formation of autocrine growth loops that then circumvent the growth inhibition of antiandrogen drugs.
Our lab has begun the development of highly specific CaP PAM inhibitors as a means of further elucidating the role of PAM in the progression to hormone-refractory CaP and evaluating PAM as a potential CaP therapeutic target. As is customary in the literature, we define PAM activity by PHM conversion, the first enzymatic step of the PAM activation process. To screen large numbers of potential inhibitors, we established a simple and scalable method to produce large quantities of CaP PAM. Previous CaP PAM investigations have used cytosolic and membrane-bound fractions of CaP cell line extracts, with the androgen-insensitive CaP cell lines DU145 and PC-3 yielding significant PAM extract activity levels. 9 However, this procedure yields very small quantities of extracted PAM, is time-consuming, and requires many millions of cells. On the basis of previous reports that lung cancer cell lines release substantial amounts of active PAM enzyme into their cell culture media, 7, 8 we examined CaP cell media. These preliminary CaP cell media samples exhibited substantial levels of PAM activity, so we then optimized the media collection protocol for our screening program. We provide here a comparison of the levels of PAM enzyme activity found in CaP cell extracts and different culture media, as well as offer an extremely simple protocol for quickly and easily collecting large quantities of catalytically active CaP PAM.
MATERIALS AND METHODS

Cell lines
The androgen-independent human prostate cancer cell lines DU145 and PC-3 were received from the National Cancer Institute (NCI, Bethesda, MD), whereas the androgen-dependent human prostate LNCaP cancer cell line was purchased from American Type Culture Collection (Rockville, MD). All 3 cells lines were maintained in RPMI (Sigma, St. Louis, MO) supplemented with 2.0 mM L-glutamine, 20 mM HEPES, 5% fetal bovine serum (FBS), 5% NuSerum IV (BD Biosciences, San Diego, CA), 100 IU penicillin, 100 μg/mL streptomycin, and 0.25 μg/mL amphotericin B (Fisher, Hanover Park, IL) (complete media, CM). The cells were grown at 37 °C in 95% humidified air/5% CO 2 and passaged weekly.
Cell extracts
Prior to cell extractions, cells were cultured for 1 week in steroid-depleted (SD) RPMI media, which is the same as CM except that the FBS and NuSerum IV are replaced with 1% (DU145, PC-3) or 2.5% (LNCaP) dextran-coated, charcoaltreated SD fetal bovine serum (Hyclone, Logan, UT). The media were collected at the start of the cell extraction procedures, cells were rinsed twice with ice-cold phosphate-buffered saline (PBS), and scraped into ice-cold PBS. Cells were pelleted by centrifugation (100 g, 5 min, 4 °C); resuspended in 7 mL of 20 mM TES/10 mM mannitol buffer (pH 7.4) containing phenylmethylsulfonyl fluoride (PMSF), protease inhibitors, and 1 μM CuSO 4 (TES buffer) per T225 cell flask used; and then homogenized via 30 strokes with a chilled Dounce homogenizer. The homogenized cells were centrifuged (1000 g, 5 min, 4 °C), the supernatant (S1) containing the cytosolic and membrane fractions was withdrawn, and the pellet containing the nuclear fraction (P1) was resuspended in TES buffer. A 0.2-mL sample of supernatant (S1) was saved for subsequent activity testing, with the remainder ultracentrifuged at 30,000 g for 30 min at 4 °C. Supernatant was withdrawn and saved as cytosolic PAM (S30), and pellet was resuspended in 3.5 mL of TES buffer containing 1% Triton-X 100 (TES/1% Triton-X buffer) per T225 cell flask used. A 0.2-mL sample of resuspended pellet (P30) was again saved for subsequent activity assay, with the remainder centrifuged at 100,000 g for 60 min at 4 °C. The supernatant of this final step (S100) represented the membrane-bound PAM. The insoluble pellet fraction (P100) was resuspended in TES/1% Triton-X buffer. All samples were collected on ice, glycerol was added to 10% by volume, and samples were stored at -80 °C until analysis.
Media collection
Cells were passaged and cultured in CM for 3 days prior to the start of experiments to ensure proper cell attachment. The media were then replaced with fresh CM, SD media, or serum-free TIS media (RPMI containing all the supplements of CM except serum is replaced with 10 μg/mL transferrin, 10 μg/mL insulin, and 10 ng/mL selenium). The initial media replacement was taken as day 0 of the experiment, and fresh blank media samples were collected for background activity analysis. The media were then collected and replaced with fresh media on days 4, 9, 14, 18, and 23.
Glycerol was added to 10% by volume to media samples, aliquoted in 1.0-mL samples, and stored at -80 °C until assayed for activity.
Activity assay
PAM activity was measured using a trinitrophenylated (TNP) terminal-glycine substrate, TNP-DTyr-Val-Gly, previously described in the literature. 14 The TNP substrate, along with the corresponding α-hydroxylated intermediate and terminal-amide PAM product, was synthesized in our laboratory and structurally verified by proton NMR and carbon, hydrogen, and nitrogen (CHN) analysis. Activity assays were carried out in a 200-μL reaction mixture containing 150 mM sodium MES (Sigma) buffer, 10.0 mM Lascorbate (Sigma), copper sulfate (Sigma) either at 1.0 μM for media samples or 10.0 μM for CaP cell extract samples, 1.0% ethanol (Pharmaco Products, Brookfield, CT), 1.0% DMSO (Fisher), 0.1 mg/mL beef liver catalase (Sigma), 50.0 μM TNP substrate, and 20 μL media or cell extract sample. A solution containing all agents except catalase, substrate, and enzyme sample was prepared fresh daily, adjusted to pH 5.8, and stored at 4 °C until use. The optimum pH, ascorbate, and copper sulfate levels were determined in preliminary activity experiments, with the higher copper sulfate levels required for CaP cell PAM extracts, in agreement with Rocchi et al. 9 Catalase and TNP substrate were added immediately prior to testing, the solution was aliquoted into 1.5-mL microcentrifuge tubes (without lids to allow oxygen delivery for the reaction), and briefly preheated to 37 °C. The enzyme samples were thawed and added to the tubes, and the reaction mixture tubes were incubated in a dry bath at 37 °C for 2 h with orbital shaking. At the end of the incubation period, enzyme reactions were stopped by adding 20 μL chilled 3.0 M perchloric acid (Aldrich, Milwaukee, WI). Tubes were then spun at 16,000 g for 2 min at 4 °C. Supernatant was transferred to an autosample vial and stored at 4 °C until high-performance liquid chromatography (HPLC) analysis. Addition of enzyme sample, perchloric acid, and solution transfers was performed on a Packard Multi-Probe II HTS Liquid Handling System to ensure consistent, efficient, and accurate liquid transfers at a high rate of sample throughput. Protein concentrations of all media and cell extract samples were determined using microBCA assay reagents (Pierce Biotechnology, Inc., Rockford, IL) with bovine serum albumin (BSA) standards.
HPLC to 50 μM product were prepared fresh in blank incubation mix each day and analyzed at the beginning, middle, and end of each HPLC run. Calibration curves generated from the standard peak areas using a power law equation fit were used to quantify analyte levels in the activity samples. The amount of substrate conversion by PAM enzyme was calculated by summing the levels of intermediate and product in each incubation sample.
Inhibitor studies
PAM enzyme inhibition tests were performed in the same manner as described for the activity assays, except that positive or negative standard inhibitors were added at the beginning of the incubation period. Positive PAM inhibitors included copper chelators disulfiram (Antabuse, Aldrich) and diethyldithiocarbamate (DDC, Aldrich), as well as the substrate-like inhibitor 4phenyl-3-butanoic acid (PBA, Aldrich). The neurotransmitter dopamine is the product of the enzyme dopamine β-hydroxylase, which has some homology with the PAM enzyme, but dopamine has very low PAM inhibitory activity and has been used as a negative control in these tests. Each inhibitor test included duplicate tubes at 5 serial dilution concentrations along with inhibitor-free controls. Inhibitors were evaluated via 3 sets of tests for each type of media PAM sample being tested. A standard Dixon plot analysis 15 fit the measured inhibition data for PBA and dopamine very well but did not properly fit the inhibition measurements for either of the copper chelators. The Hill equation gave excellent fits to the data for all 4 inhibitors and gave statistically identical IC 50 values to the Dixon plot for PBA and dopamine, so Hill equation fits were used to evaluate IC 50 values for each inhibitor. Values of K i for each inhibitor were then estimated from the IC 50 values using the simple competitive inhibitor model relationships. 15 It should be noted that the copper chelators likely do not follow a competitive inhibitor model, so the calculated K i values for these inhibitors are provided for crude comparison purposes only. The K m values used for each media PAM source in these calculations were estimated by Lineweaver-Burke analysis of kinetic rates measured without inhibitor in duplicate tubes at 6 serial dilution concentrations of the TNP-DTyr-Val-Gly substrate.
Western blot
From DU145, PC-3, and LNCaP TIS media samples, 20 μg of total protein was loaded onto a 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gel, electrophoresed, and transferred to a polyvinylidene fluoride (PVDF) membrane. After blocking nonspecific binding with 5% nonfat milk in Tris-buffered saline containing 0.1% Tween 20 (TBST), the membrane was incubated overnight at 4 °C with primary PHM antibody (1761), exon A antibody (629), and C-terminal PAM antibody (CT267) diluted 1:1000 (kind gifts of Dr. Betty Eipper, University of Connecticut Health Center, Farmington 16 ). After washing, the membrane was incubated with secondary antibody (1:15,000, Sigma) and bands visualized using enhanced chemiluminescence (Pierce).
RESULTS AND DISCUSSION
Rocchi et al. 9 isolated PAM from DU145 and PC-3 prostate cancer cell lines in a process that is time-consuming and laborious, requires a large amount of cells and reagents, and yields very small quantities of enzyme. Vos et al. 7 tested lung cancer cell lines and found that these cells release significant amounts of PAM enzyme into the media. Using the prostate cancer cell lines DU145, PC-3, and LNCaP, we evaluated the PHM activity in media, membrane, and cytosolic cell fractions after 5 days in culture. Results indicate that there is very little substrate conversion in any of the extracts or media from LNCaP cells as expected. However, DU145 and PC-3 show high PHM conversion and high PHM activity levels in the media and the S100 fraction, respectively (Fig. 1a,b) . However, when normalized to total protein or media volume, it is clear that there is more PHM activity in the media of DU145 and PC-3 cells than in all of the cell extract fractions combined (Fig. 1c) . In fact, when based on the relative proportion of total PHM activity collected from 1 T225 flask, more than 90% of PHM activity is found in the media of DU145 and PC-3 cells compared with all other extract fractions combined.
To compare PAM production in prostate cancer cells in different serum conditions, we cultured cells in conditioned media, 1% (DU145 and PC-3) or 2.5% SD media (LNCaP), or TIS media. These conditions were chosen to represent standard culturing conditions, the SD culturing conditions based on Rocchi et al., 9 and media containing minimal added proteins and nutrients (TIS) based on Iwai et al., 8 respectively. Media samples were collected over a time course of 23 days to determine if PAM levels in the media change with culture time. After 9 days in culture, PHM activity was elevated in all media conditions for both DU145 and PC-3 cell lines. Figure 1a,b shows representative amounts of PHM activity at day 14 for all 3 cell lines in the 3 media conditions (CM, SD, TIS). As expected, LNCaP had little or no PHM activity in any media condition at any time point. Specific activity levels normalized to protein content (Fig. 1b) show similar trends, with DU145 and PC-3 having the highest specific PHM activity in TIS media compared with CM or SD. Protein levels for a given cell line and media type exhibited little variation after 4, 9, 14, 18 , and 23 days in culture, and hence only average culture values have been reported. Although cell passage number varied for the cell lines during these tests, there was no consistent correlation between cell passage number and the amount of PAM expression. CM has the highest protein content due to exogenous proteins in the added 10% serum (3.47 ± 0.06 mg/mL), SD media have moderate protein levels reflecting the lower 1% to 2.5% added serum levels (2.34 ± 0.59 mg/mL), whereas serum-free TIS media have the lowest protein levels (1.17 ± 0.07 mg/mL).
Inhibitor studies demonstrate that PHM activity on TNP-D-Tyr-Val-Gly is reduced by low levels of known PHM inhibitors, verifying that PAM is the active protein present in the media (see Table 1 ). Fresh Media Cell Media Cell Homog S1 P1 S30 P30 S100 P100
Total PHM Extract Activity the high nM to low μM range, whereas the IC 50 for the negative control inhibitor dopamine is about 3 magnitudes higher. The Z factor, 17 calculated from the DU145 TIS media IC 50 for disulfiram (positive control) and dopamine (negative control), is 0.66, indicating that the methods used here provide an excellent quantitative differentiation of PHM inhibition activity. PHM expression was further verified by Western blot analysis using PHM-specific antibodies kindly donated by Dr. Betty Eipper (Fig. 2) . Because there can be alternatively spliced variants of PAM, the PHM antibody recognized 3 different variants of soluble PAM around 100 kDa noted by the triplet in Figure  2 . A faint band also appeared around 40 kDa in the DU145 media sample, indicating soluble PHM not including the PAL region (data not shown). Antibodies to the C-terminus of PAM, which binds to membrane-bound PAM, and to exon A, which is present in insoluble forms of PAM, did not recognize secreted PAM in the media samples as expected (data not shown).
The method described in this article offers a simple and scalable alternative to cell extraction. PAM-enriched media can easily be collected from CaP cell cultures, with the amount of PAM collected limited solely by the number and size of culture flasks employed (approximately 6 × 10 6 DU145 or PC-3 cells and 2 × 10 7 LNCaP cells per T225 flask containing 36 mL media). The media can be stored frozen for later use in inhibition assays or enzyme purification. PAM enzymes collected in serum-free TIS media are especially ideal for these purposes, as the resulting lower levels of contaminating proteins reduce nonspecific protein binding during inhibition testing and minimize the amount of unwanted proteins that must be removed during purification. Besides CaP and SCLC cell lines, we have found the simple media collection technique described here to work equally well with other types of human cell lines, including muscle and thyroid cell lines (data not shown). The ease of these methods allows evaluation of other tissues/cells and compounds to be evaluated in a very short time. Using the activity assay described herein, it is possible to screen more than 1500 compounds from as few as 6 × 10 6 cells. 
